Lupin U.S. Unit Recalls 10,000 Bottles Of Suprax Antibiotic For Impurities
This article was originally published in PharmAsia News
Executive Summary
Lupin Pharmaceuticals, the India drug maker's U.S. unit, ordered a recall of nearly 10,000 bottles of its Suprax (cefixime) antibiotic for treating ear and upper respiratory tract infections.